RxDoctor Payments Data

Monica Khot, MD

Cardiovascular Disease · Cleveland, OHNPI 1912978446

Payments from drug & device makers

$296in general payments, 2019–2025

Across 14 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$102
  • Novartis$55
  • Amgen$29
  • Lantheus Medical Imaging, Inc.$25
  • Abbott$21
  • Boehringer Ingelheim$18
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$296 in reported general payments places this provider in the 20th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio

Medicare billing

Part B allowed, 2024
$33,784
Medicare patients
146
Services billed
631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban136$145,020
Repatha SureclickEvolocumab31$44,239
EntrestoSacubitril/Valsartan21$26,113
XareltoRivaroxaban13$17,162
Metoprolol Succinate685$11,137
Rosuvastatin Calcium422$6,461
Nifedipine ErNifedipine195$5,825
BrilintaTicagrelor12$5,098
Atorvastatin Calcium290$3,851
Diltiazem 12hr ErDiltiazem Hcl12$2,672
Isosorbide Mononitrate ErIsosorbide Mononitrate201$2,609
Ezetimibe168$2,514
Clonidine31$2,495
Carvedilol168$2,271
Telmisartan104$2,062

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$55$26,11321 claims
AstraZenecaBrilinta$16$5,09812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 827 cardiovascular disease providers in Ohio.

Other cardiovascular disease in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →